BSE Live
Dec 08, 16:01Prev. Close
1750.55
Open Price
1750.55
Bid Price (Qty.)
1664.10 (1)
Offer Price (Qty.)
1703.00 (99)
NSE Live
Dec 08, 15:58Prev. Close
1751.60
Open Price
1745.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1699.60 (347)
| Cash Flow of Gland Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,465.59 | 1,405.50 | 1,048.40 | 1,619.04 | 1,334.85 | |
| Net CashFlow From Operating Activities | 1,073.67 | 1,135.97 | 367.89 | 791.29 | 604.93 | |
| Net Cash Used In Investing Activities | 1,578.20 | -2,923.92 | 1,208.22 | -1,010.23 | -1,524.55 | |
| Net Cash Used From Financing Activities | -339.54 | -7.40 | 14.92 | 34.90 | 1,238.46 | |
| Foreign Exchange Gains / Losses | 4.09 | 6.34 | 3.00 | 3.31 | 3.58 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2,316.42 | -1,789.01 | 1,594.04 | -180.73 | 322.42 | |
| Cash And Cash Equivalents Begin of Year | 116.21 | 1,905.22 | 311.18 | 491.92 | 169.50 | |
| Cash And Cash Equivalents End Of Year | 2,432.62 | 116.21 | 1,905.22 | 311.18 | 491.92 |
10.11.2025
Gland Standalone September 2025 Net Sales at Rs 1,074.15 crore, up 1.05% Y-o-Y
04.11.2025
04.11.2025
Gland Consolidated September 2025 Net Sales at Rs 1,486.88 crore, up 5.76% Y-o-Y
20.09.2025
Chartist Talk: Has Nifty 50 entered the third wave of its uptrend to reclaim record highs by Diwali?
10.11.2025
Gland Standalone September 2025 Net Sales at Rs 1,074.15 crore, up 1.05% Y-o-Y
04.11.2025
Gland Consolidated September 2025 Net Sales at Rs 1,486.88 crore, up 5.76% Y-o-Y
03.11.2025
Gland Pharma net profit rises 12%YoY to Rs 183.7 crore in Q2FY26
12.08.2025
Gland Consolidated June 2025 Net Sales at Rs 1,505.62 crore, up 7.41% Y-o-Y